Marc Julien, co-CEO of Diabeloop, presents the revolutionary “artificial pancreas” the company has developed to support type one diabetes patients. The device embeds artificial intelligence to help type one diabetics regulate their insulin intake according to their needs. He also discusses the opportunities and challenges he sees to bring such a device on the French market.
France is renowned for bringing together academics and technology institutes. They work brilliantly together, but the country is missing the investment steps to commercialize the solutions
